D-003, a potential antithrombotic compound isolated from sugar cane wax with effects on arachidonic acid metabolites.

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Prostaglandins, Leukotrienes and Essential Fatty Acids

• Publication date

  2002-07-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1054/PLEF.2002.0376PMID 12213431
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Acute and oral subchronic toxicity of D-003 in rats.

  2000cited by this paper
• Dose-dependent cholesterol-lowering effects of d-003 on normocholesterolemic rabbits

  2000cited by this paper
• Antiplatelet and antithrombotic effect of D-003.

  2000cited by this paper
• Platelet‐endothelial interactions in atherothrombotic disease: Therapeutic implications

  1999cited by this paper
• Hydrogen peroxide is involved in collagen-induced platelet activation.

  1998cited by this paper
• Results of the CAPRIE trial: efficacy and safety of clopidogrel

  1998cited by this paper
• Analysis of urinary 11-dehydrothromboxane B2 in patients with occluded retinal vein using GC/SIM.

  1998cited by this paper
• Losartan inhibits experimental venous thrombosis in spontaneously hypertensive rats.

  1998cited by this paper
• Clinical considerations in selecting antiplatelet therapy in cerebrovascular disease.

  1998cited by this paper
• Lipid peroxide overcomes the inability of platelet secretory phospholipase A2 to hydrolyze membrane phospholipids in rabbit platelets.

  1997cited by this paper
• Oxygen free radicals and platelet activation.

  1997cited by this paper
• Interactions between dietary fat, fish, and fish oils and their effects on platelet function in men at risk of cardiovascular disease.

  1997cited by this paper
• Aspirin related gastrointestinal bleeders have an exaggerated bleeding time response due to aspirin use.

  1996cited by this paper
• Changes in the haemostatic profile during magnesium deficiency in swine.

  1996cited by this paper
• Endothelial function in different organs.

  1996cited by this paper
• A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee.

  1996cited by this paper
• Platelet activation and arterial thrombosis

  1994cited by this paper
• Collaborative overview of randomised trials of antiplatelet therapy Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients

  1994cited by this paper
• Platelet activation and arterial thrombosis. Report of a meeting of Physicians and Scientists, University of Texas Health Science Center at Houston and Texas Heart Institute, Houston.

  1994cited by this paper
• Collaborative overview of randomised trials of antiplatelet therapy--I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration.

  1994cited by this paper
• Importance of platelets in experimental venous thrombosis in the rat.

  1992cited by this paper
• The Canadian American Ticlopidine Study (CATS) in thromboembolic stroke.

  1989cited by this paper
• Thromboxane synthase inhibitors. Synthesis and pharmacological activity of (R)-, (S)-, and (+/-)-2,2-dimethyl-6-[2-(1H-imidazol-1-yl)-1-[[(4-methoxyphenyl)- methoxy]methyl]ethoxy]hexanoic acids.

  1987cited by this paper
• Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factor

  1986cited by this paper
• A sensitive model of venous thrombosis in rats.

  1986cited by this paper
• The role of platelets in the development and complications of atherosclerosis.

  1986cited by this paper
• Effect of cilostazol on platelet aggregation and experimental thrombosis.

  1985cited by this paper
• Reorientation of prostaglandin endoperoxide metabolism by a thromboxane synthetase inhibitor: in vitro and clinical observations.

  1983cited by this paper
• A thromboxane synthetase inhibitor reorients endoperoxide metabolism in whole blood towards prostacyclin and prostaglandin E2.

  1982cited by this paper
• Thromboxane B2 and 6-keto-prostaglandin F1 alpha synthesis during infusion of collagen and arachidonic acid in rabbits: inhibition by aspirin and sulfinpyrazone.

  1980cited by this paper
• Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction.

  1979cited by this paper
• Effects of indomethacin and sulfinpyrazone on in vivo formation of thromboxane B2 and prostaglandin D2 during arachidonate infusion in rabbits.

  1978cited by this paper
• Differential formation of prostacyclin (PGX or PGI2) by layers of the arterial wall. An explanation for the anti-thrombotic properties of vascular endothelium.

  1977cited by this paper
• On the formation and effects of thromboxane A2 in human platelets.

  1976cited by this paper
• An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation

  1976cited by this paper
• Arterial walls are protected against deposition of platelet thrombi by a substance (prostaglandin X) which they make from prostaglandin endoperoxides.

  1976cited by this paper
• Intravenous arachidonate in the mouse: a model for the evaluation of antithrombotic drugs.

  1976cited by this paper
• A lipid peroxide inhibits the enzyme in blood vessel microsomes that generates from prostaglandin endoperoxides the substance (prostaglandin X) which prevents platelet aggregation.

  1976cited by this paper
• Arterial walls generate from prostaglandin endoperoxides a substance (prostaglandin X) which relaxes strips of mesenteric and coeliac ateries and inhibits platelet aggregation.

  1976cited by this paper
• Prostaglandin endoperoxides IX. Characterization of rabbit aorta contracting substance (RCS) from guinea pig lung and human platelets.

  1975cited by this paper
• Thromboxanes: a new group of biologically active compounds derived from prostaglandin endoperoxides.

  1975cited by this paper
• Arachidonic Acid Causes Sudden Death in Rabbits

  1974cited by this paper

• Advances in safe processing of sugarcane and bagasse for the generation of biofuels and bioactive compounds

  2023cites this paper
• Experimental antithrombotic effect of medicinal plants: A critical review

  2022cites this paper
• D-003 (

  2021cites this paper
• The benefit of Indian jaggery over sugar on human health

  2020cites this paper
• Vallarai Nei for the Management of Iron Deficiency Anemia (Veluppu Noi) In Children – A Review

  2020cites this paper
• ANTITHROMBOTIC ACTIVITY OF TAMARINDUS INDICA L. IN MICE

  2018influential citation
• Potential Health Benefits of Sugarcane

  2017cites this paper
• D-003 (Saccharum officinarum): The forgotten lipid-lowering agent.

  2016cites this paper
• The Role of Platelets in Venous Thromboembolism

  2016cites this paper
• 1 D-003 ( Saccharum officinarum ) : THE FORGOTTEN LIPID-LOWERING AGENT

  2016cites this paper
• High doses of D-003, an antiplatelet drug purified from sugar cane wax, on bleeding time and coagulation indexes in rats

  2015cites this paper
• Phytochemical profile of sugarcane and its potential health aspects

  2015influential citation
• Efectos del D-003 sobre patrones conductuales de roedores

  2015cites this paper
• Estudio de estabilidad a largo plazo de lotes industriales de D003 ingrediente activo. Long-term stability study of industrial batches of D003 active ingredient.

  2010cites this paper
• Efectos del D-003 sobre daño endotelial inducido por citrato de sodio en ratas

  2010cites this paper
• Study of the long-term carcinogenicity potential of D-003, a mixture of high molecular weight sugarcane wax acids, in mice.

  2009cites this paper
• Cardioactive agents from plants.

  2009cites this paper
• Effects of D-003, a Mixture of Sugarcane Wax Acids, on Platelet Aggregation in Hypercholesterolemic Patients

  2008cites this paper
• Long-term carcinogenicity of D-003, a mixture of high molecular weight acids from sugarcane wax, in Sprague Dawley rats: a 24 months study.

  2007cites this paper
• Perinatal/Postnatal Study of D-003, a Mixture of Long-Chain Fatty Acids, in Rats

  2006cites this paper
• Effect of D-003, a Mixture of Very-Long-Chain Aliphatic Acids Purified from Sugarcane Wax, on Cerebral Ischemia in Mongolian Gerbils

  2005cites this paper
• Toxicidad aguda oral del D-003 en conejos F1

  2005cites this paper
• FarmacologÌa de los agentes antiagregantes plaquetarios

  2005cites this paper
• Effect of D-003 on Intravascular Platelet Aggregation Induced with Collagen in Rats

  2005cites this paper
• Effect of D-003 on Intimal Thickening and Circulating Endothelial Cells in Rabbit Cuffed Carotid Artery

  2005cites this paper
• Effects of D-003, a mixture of very long chain fatty acids purified from sugar cane wax, at 5 and 10 mg/day on platelet aggregation in healthy volunteers.

  2005cites this paper
• Lack of Protective Effect of D-003, a Mixture of High-Molecular-Weight Primary Acids from Sugar Cane Wax, on Liver Damage Induced by Galactosamine in Rats

  2005cites this paper
• Carcinogénesis del D-003 en ratas Sprague Dawley. Reporte de un año.

  2005cites this paper
• D-003 and Warfarin Interaction on the Bleeding Time and Venous Thrombosis Experimentally Induced in Rats

  2004cites this paper
• Protective effect of D-003 on experimental spinal cord ischemia in rabbits.

  2004cites this paper
• Effects of d-003, a new substance purified from sugar cane wax, on platelet aggregation and plasma levels of arachidonic acid metabolites in healthy volunteers.

  2004cites this paper
• Effects of D-003 on Hepatic Drug-Metabolizing Enzyme Activities in Rats

  2004cites this paper
• Effects of chronic administration of D-003, a mixture of sugar cane wax high molecular acids, in beagle dogs.

  2004cites this paper
• Effect of D-003 on a Subconvulsive Dose of Kainic Acid in Rats

  2004cites this paper
• Evaluation of the reproductive and developmental toxicity of the D-003, a mixture of long-chain fatty acids, in rats and rabbits.

  2004cites this paper
• Synergistic effect of D-003 and aspirin on experimental thrombosis models.

  2003cites this paper
• Effect of D-003 on Isoproterenol-Induced Myocardial Necrosis in Rats

  2003cites this paper
• Efecto del D-003 sobre el infarto del miocardio inducido por ligadura y reperfusión de la coronaria en ratas.

  2003cites this paper
• Effect of D-003, a mixture of high molecular weight primary acids from sugar cane wax, on paracetamol-induced liver damage in rats.

  2003cites this paper
• Efecto del D-003 sobre los niveles de endotelemia en no roedores

  2003cites this paper
• Six-Month Toxicity Study of Oral Administration of D-003 in Sprague Dawley Rats

  2002cites this paper